Overview
- Gives a complete knowledge of the different lung diseases
- Discusses the pathophysiology of the specific diseases in a detailed manner
- Provides in depth details of current treatments and future perspectives
Buy print copy
About this book
Various key lung diseases are covered, including chronic obstructive pulmonary disease, lung cancer, tuberculosis, chronic pneumonia, acute respiratory distress syndrome, asthma, cystic fibrosis and pulmonary hypertension. Medical students and researchers whose work involves pulmonary related disorders will find this work both instructive and informative.
Similar content being viewed by others
Keywords
Table of contents (8 chapters)
Editors and Affiliations
About the editors
Sheikh Rayees is a pharmacologist working at the University of Illinois at Chicago, USA. He completed his MSc. In Biotechnology at HNB Garhwal University (a Central University) followed by his doctoral degree at the prestigious CSIR-Indian Institute of Integrative Medicine and SMVDU, Jammu, India. Mr. Rayees is currently working towards understanding the biology and therapeutics of respiratory disorders like acute lung injury, acute respiratory distress syndrome etc. He has published several articles in leading peer-reviewed journals and has sound academic credentials. Mr. Rayees received several awards throughout his doctoral and postdoctoral research career.
Inshah Din is a research scholar working at Govt. Medical College, Srinagar. She completed her M.Sc. in Clinical Biochemistry, followed by an M.Phil. and Ph.D. in Biochemistry at the University of Kashmir. She has worked as a Junior Research fellow at the prestigious Sher-i-Kashmir Institute of Medical Sciences, Srinagar. Ms. Din has sound academic credentials, and has published several research articles in peer-reviewed journals.
Fayaz Malik is an Indian cancer biologist and pharmacologist at the prestigious CSIR-Indian Institute of Integrative Medicine. He is known for his studies on investigating the regulatory mechanisms of cancer stem cells during tumor metastasis. He has also studied the identification of signaling networks that confer resistance to current anti-cancer therapies. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the most coveted Indian science awards, for his contributions to the Biosciences in 2014. In addition, the Department of Science and Technology of the Government of India awarded him the Swaranajayanti Fellowship, one of the most prestigious Fellowship awards, for his advanced researchin cancer biology.
Gurdarshan Singh is a pharmacologist working as a principal scientist at the prestigious CSIR-Indian Institute of Integrative Medicine. He completed his M.Sc., M.Phil. and Ph.D. at Jammu University, India. Mr. Gurdarshan is currently Head of the PK-PD Toxicology Division at the CSIR-Indian Institute of Integrative Medicine, Jammu. His main research interests include evaluating new and potent drug-like molecules for their safety pharmacology, pharmacodynamic and pharmacokinetic properties. He has worked in several areas of pre-clinical research, e.g. asthma, hypertension and cancer. Dr. Singh holds several patents and contributed to the development of Risorine, an anti-tuberculosis drug and the world’s first boosted-rifampicin treatment with a fixed-dose combination.
Bibliographic Information
Book Title: Chronic Lung Diseases
Book Subtitle: Pathophysiology and Therapeutics
Editors: Sheikh Rayees, Inshah Din, Gurdarshan Singh, Fayaz A Malik
DOI: https://doi.org/10.1007/978-981-15-3734-9
Publisher: Springer Singapore
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Nature Singapore Pte Ltd. 2020
Hardcover ISBN: 978-981-15-3733-2Published: 21 July 2020
Softcover ISBN: 978-981-15-3736-3Published: 22 July 2021
eBook ISBN: 978-981-15-3734-9Published: 20 July 2020
Edition Number: 1
Number of Pages: VIII, 180
Number of Illustrations: 2 b/w illustrations, 4 illustrations in colour
Topics: Biomedicine, general